版本:
中国

BRIEF-Pfizer says for co’s U.S. biopharma business as of the first quarter, the weighted average net selling price increase YTD is 4 pct in the U.S.

June 2 Pfizer Inc:

* "For Pfizer’s US Biopharma business as of the first quarter, the weighted average net selling price increase YTD is 4% in the US"‍​ Further company coverage: (Bengaluru Newsroom: +91 806 749 1136)

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐